<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.817666</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20250224155733</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">160513s1987    onc     o    f|00 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H46-2/87-127E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="100" ind1="1" ind2=" ">
      <marc:subfield code="a">Stuchly, M. A.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Guidelines on exposure to electromagnetic fields from magnetic resonance clinical systems </marc:subfield>
      <marc:subfield code="h">[electronic resource] / </marc:subfield>
      <marc:subfield code="c">[prepared by M.A. Stuchly] ; Environmental Health Directorate, Health Protection Branch.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health and Welfare Canada, </marc:subfield>
      <marc:subfield code="c">[1987].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">v, 20 p.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="490" ind1="0" ind2=" ">
      <marc:subfield code="a">Safety code ; </marc:subfield>
      <marc:subfield code="v">26</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="490" ind1="0" ind2=" ">
      <marc:subfield code="a">EHD (Series) ; </marc:subfield>
      <marc:subfield code="v">87-EHD-127</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"Archived."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Publication replaced on February 24, 2025 as requested by the publisher.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Lignes directrices sur l'exposition aux champs électromagnétiques provenant d'appareils cliniques à résonance magnétique.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographic references.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1="3" ind2=" ">
      <marc:subfield code="a">Magnetic resonance imaging (MRI) and recently also magnetic resonance spectroscopy (MRS) have been gaining a widespread acceptance and many applications in clinical settings. These imaging devices utilize three types of fields, namely, the static magnetic field, the time-varying magnetic field and the radiofrequency (RF) field. Since each of the fields produced by MRI or MRS devices, if of a sufficient intensity, can produce detrimental biological effects, questions have been raised regarding the safety of these devices. Guidelines on device characteristics and patient and operator exposure have been published in some countries (the United States, the United Kingdom, the Federal Republic of Germany). This document briefly reviews biological effects of various fields used in magnetic resonance devices and provides general guidance on exposure levels to the patient and to the operator. The levels cited should not be considered as strict limits which if exceeded would result in a dangerous situation, but rather indicate the presently established levels below which potential hazards, if any, are considered minimal, if any. Higher exposure levels may still be safe, depending on various factors. For patient exposures exceeding the specified safe limits, the usual risk-benefit assessment has to be made.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Medical technology</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Safety</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Health Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Lignes directrices sur l'exposition aux champs électromagnétiques provenant d'appareils cliniques à résonance magnétique </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.817669</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">84.4 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2025/sc-hc/H46-2-87-127-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
